Bulk QSC Tirzepatide Powder - GIP/GLP-1 Receptor Agonist for Diabetes Research

QSC Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.

The molecular structure of QSC Tirzepatide enables it to bind with greater affinity to GIP receptors while maintaining significant activity at GLP-1 receptors. This unique dual mechanism has shown promising results in metabolic research applications.

Our QSC Tirzepatide is produced under strict pharmaceutical-grade conditions, ensuring consistent quality and purity for research purposes. The product is supplied as a white powder with excellent stability characteristics when stored properly.

For research use only. Not for human consumption.